Shanghai Bao Pharmaceuticals Co., Ltd.
Research Shanghai Bao Pharmaceuticals Co., Ltd. (2659.HK) on Bullrun: market cap HKD 3.10B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker2659.HK
- ExchangeHK
- CountryChina
- SectorHealthcare
- IndustryBiotechnology
- CurrencyHKD
- Market capHKD 3.10B
- Financial periodFY2025
- RevenueCNY 49.16M
- Revenue growth698.0%
- Net income-CNY 395.30M
- Free cash flow-CNY 333.41M
- Gross margin89.0%
Valuation Snapshot
latest market cap is HKD 3.10B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 49.16M | -CNY 395.30M | -CNY 333.41M | 89.0% | -1.36 | CNY 1.33B | CNY 315.00M | CNY 1.59B |
| FY2024 | CNY 6.16M | -CNY 364.43M | -CNY 338.06M | 81.5% | -1.12 | CNY 609.36M | CNY 205.26M | CNY 995.88M |
| FY2023 | CNY 6.93M | -CNY 160.40M | -CNY 276.58M | 97.8% | -0.49 | CNY 321.67M | CNY 111.12M | CNY 749.13M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 3.10B | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 HKD.
About Shanghai Bao Pharmaceuticals Co., Ltd.
Shanghai Bao Pharmaceuticals Co., Ltd., a biotechnology company, engages in the research, development, and commercialization of pharmaceutical products in Mainland China. The company uses synthetic biology technology to develop and deliver recombinant biologic drugs. Its products include KJ017, a recombinant human hyaluronidase for subcutaneous drug delivery; KJ103, a recombinant immunoglobulin G (IgG)-degrading enzyme for IgG-mediated autoimmune diseases;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Shanghai Bao Pharmaceuticals Co., Ltd.'s market cap?
Shanghai Bao Pharmaceuticals Co., Ltd.'s market capitalization is HKD 3.10B.
What does Shanghai Bao Pharmaceuticals Co., Ltd. do?
Shanghai Bao Pharmaceuticals Co., Ltd., a biotechnology company, engages in the research, development, and commercialization of pharmaceutical products in Mainland China. The company uses synthetic biology technology to develop and deliver recombinant biologic drugs.